TY - JOUR
T1 - Interactions between gallamine and muscarinic receptors
T2 - allosterism and subpopulation specificity are separate phenomena
AU - Ellis, John
AU - Seidenberg, Margaret
N1 - Funding Information:
Supportedb y PHS R01 AG05214a nd a grant from the CummingsM emorialFund of the AmericanF ederationfo r Aging Research.
PY - 1987/11/24
Y1 - 1987/11/24
N2 - The quaternary antagonist gallamine discriminates subpopulations of muscarinic receptors in the forebrain and brainstem of the rat and also modulates the binding of other muscarinic ligands via an allosteric mechanism in both brain regions. The calcium channel antagonist verapamil exhibits a similar allosteric effect in both regions (at 100 μM) but does not differentiate the subpopulations that are defined by gallamine. On the other hand, N-methylatropine does not produce the allosteric effect at 100 μM, but shows a high degree of selectivity (about 1000-fold) for the gallamine-defined subpopulations. These studies indicate that the allosterism and subpopulation specificity of gallamine are separate phenomena and may be examined in isolation by appropriate ligands.
AB - The quaternary antagonist gallamine discriminates subpopulations of muscarinic receptors in the forebrain and brainstem of the rat and also modulates the binding of other muscarinic ligands via an allosteric mechanism in both brain regions. The calcium channel antagonist verapamil exhibits a similar allosteric effect in both regions (at 100 μM) but does not differentiate the subpopulations that are defined by gallamine. On the other hand, N-methylatropine does not produce the allosteric effect at 100 μM, but shows a high degree of selectivity (about 1000-fold) for the gallamine-defined subpopulations. These studies indicate that the allosterism and subpopulation specificity of gallamine are separate phenomena and may be examined in isolation by appropriate ligands.
UR - http://www.scopus.com/inward/record.url?scp=0023521765&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023521765&partnerID=8YFLogxK
U2 - 10.1016/0014-2999(87)90006-9
DO - 10.1016/0014-2999(87)90006-9
M3 - Article
C2 - 3436360
AN - SCOPUS:0023521765
SN - 0014-2999
VL - 144
SP - 39
EP - 44
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1
ER -